文献速递腹部技术与安全PETCT

脂肪组织代谢活性在结直肠癌FDG PET/CT中的价值

Usefulness of metabolic activity of adipose tissue in FDG PET/CT of colorectal cancer.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

回顾性纳入176例根治性手术的结直肠癌患者,测量FDG PET/CT上皮下和内脏脂肪组织的体积与代谢活性及原发肿瘤SUV。内脏脂肪SUV与肿瘤FDG摄取相关,且为无复发生存期的独立预后因素。

要点

  • 内脏脂肪SUV(而非肿瘤SUV)是结直肠癌根治术后无复发生存的独立预后因素。
  • 内脏脂肪SUV与皮下脂肪SUV、内脏脂肪体积均与无复发生存期相关。
  • 原发肿瘤SUV与血清C反应蛋白、内脏脂肪SUV及肿瘤大小相关,但与无复发生存期无关。

核心结论

  • 结直肠癌患者内脏脂肪SUV与原发肿瘤FDG摄取显著相关,且是无复发生存期的独立预测因素。

研究设计与样本

  • 回顾性纳入176例接受根治性手术的结直肠癌患者,测量FDG PET/CT上皮下脂肪组织(SAT)和内脏脂肪组织(VAT)的体积与代谢活性,以及原发肿瘤SUV(SUVtumor),采用log-rank检验单因素分析和多因素Cox回归分析评估预后价值。

诊断标准与关键数值

  • SUVtumor与血清C反应蛋白水平相关(r=0.242,p=0.001)。
  • SUVtumor与VAT的SUV相关(r=0.167,p=0.026)。
  • SUVtumor与原发肿瘤大小相关(r=0.341,p<0.001)。
  • 单因素分析中,VAT的SUV(p=0.009)、SAT的SUV(p=0.006)、VAT体积(p=0.015)、N分期(p<0.001)、M分期(p<0.001)、肿瘤累及切缘(p=0.001)和淋巴管侵犯(p=0.024)与无复发生存期显著相关;SUVtumor与无复发生存期无显著关联。
  • 多因素Cox回归分析中,VAT的SUV(p=0.016)、淋巴结转移(p<0.001)和肿瘤累及切缘(p=0.011)为无复发生存期的独立预后因素。

临床应用与阅片要点

  • 在结直肠癌FDG PET/CT阅片时,可关注内脏脂肪组织的SUV,其与肿瘤FDG摄取相关并可能提供预后信息。
  • 原发肿瘤SUV与无复发生存期无显著关联,不应单独用于预后判断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine the relationship between metabolic activity of adipose tissue on FDG PET/CT and prognosis in colorectal cancer.

METHODS: A total of 176 colorectal cancer patients with curative surgical resection were retrospectively enrolled. Volume and metabolic activity of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) on FDG PET/CT images were measured. The maximum standardized uptake value (SUV) of primary tumor (SUVtumor) was also obtained. Univariate analysis with log-rank test and multivariate Cox regression analyses were used to evaluate prognostic values of volume and metabolic activity of SAT and VAT as well as SUVtumor and clinicopathologic factors.

RESULTS: Of 176 patients, 26 experienced recurrence during follow-up. SUVtumor showed significant correlation with serum C-reactive protein level (r = 0.242, p = 0.001), SUV of VAT (r = 0.167, p = 0.026), and size of primary tumor (r = 0.341, p < 0.001). In univariate analysis with log-rank test, SUV of VAT (p = 0.009) and SAT (p = 0.006), volume of VAT (p = 0.015), N stage (p < 0.001), M stage (p < 0.001), tumor involvement of resection margin (p = 0.001), and lymphatic invasion (p = 0.024) were significantly associated with recurrence-free survival (RFS). However, SUVtumor showed no significant association with RFS. In multivariate Cox regression analysis, SUV of VAT (p = 0.016), presence of lymph node metastasis (p < 0.001), and tumor involvement of resection margin (p = 0.011) were independent prognostic factors for RFS.

CONCLUSIONS: The SUV of VAT in patients with colorectal cancer is significantly associated with FDG uptake of primary tumor. It is an independent predictor for RFS.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Yoo ID, Lee SM, Lee JW, et al. Usefulness of metabolic activity of adipose tissue in FDG PET/CT of colorectal cancer. Abdom Radiol (NY). 2018. PMID: 29198007. doi:10.1007/s00261-017-1418-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。